Your session is about to expire
← Back to Search
Pharmacological Study for Acute Myelogenous Leukemia
Study Summary
This trial is testing a new cancer drug to see if it is effective and has manageable side effects.
- Refractory Acute Myelogenous Leukemia
- Acute Myeloid Leukemia
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Side effects data
From 2021 Phase 1 & 2 trial • 24 Patients • NCT03010358Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
What other pharmacological research has recently been conducted?
"Presently, there are 9 clinical trials being conducted to assess the efficacy of Pharmacological Study. One trial is in its advanced Phase 3 stage and these experiments mostly take place at labs located within New york City, with a total of 14 research facilities involved."
What objectives are commonly sought through Pharmacological Study?
"The use of Pharmacological Study is a common approach when treating myocardial scintigraphy. Additionally, this type of study can be utilized to manage varying heart ailments such as atrioventricular block, coronary artery disease (CAD), and myocardial perfusion imaging."
Is there currently availability for potential participants in this trial?
"According to clinicaltrials.gov, this trial is closed and no longer enrolling patients; the initial post date was September 2nd 2015 with a last update on February 16th 2022. However, there are many other trials actively recruiting now at 1,613 sites across the world."
What overarching aims have been determined for this experiment?
"This clinical trial aims to assess the Complete remission rate (CR + CRi) within 30 days after the completion of treatment. Secondary outcomes such as Duration of response, Overall survival, and Event-free survival will be subjected to Kaplan–Meier estimation."
How many participants are being included in this medical experiment?
"This research has concluded its recruitment period, which began on September 2nd 2015 and finished February 16th 2022. If you are seeking other trials, there are currently 1604 studies pertaining to acute myeloid leukemia that require participants as well as 9 experiments concerning pharmacology in need of volunteers."
Share this study with friends
Copy Link
Messenger